XML 15 R4.htm IDEA: XBRL DOCUMENT v3.10.0.1
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended 6 Months Ended
Jul. 31, 2018
Jul. 31, 2017
Jul. 31, 2018
Jul. 31, 2017
Income Statement [Abstract]        
Sales-net of slotting fees and discounts $ 5,640,830 $ 7,005,434 $ 13,382,824 $ 12,362,735
Costs of Sales 3,578,840 4,652,820 8,492,288 8,067,627
Gross profit 2,061,990 2,352,614 4,890,536 4,295,108
Operating expenses:        
Research and development 37,083 33,333 67,179 67,331
General and administrative 1,895,081 1,953,961 4,140,018 3,664,678
Total operating expenses 1,932,164 1,987,294 4,207,197 3,732,009
Income from operations 129,826 365,320 683,339 563,099
Other expenses        
Interest expense (291,441) (188,230) (479,582) (372,962)
Amortization of debt discount (48,580) (8,730) (89,951) (26,010)
Total other expenses (340,021) (196,960) (569,533) (398,972)
Net income (loss) (210,195) 168,360 113,806 164,127
Less: preferred dividends (44,765) (91,565)
Net income (loss) available to common stockholders $ (210,195) $ 123,595 $ 113,806 $ 72,562
Net income (loss) per common share - basic $ (0.01) $ 0.00 $ 0.00 $ 0.00
Net income (loss) per common share - diluted $ (0.01) $ 0.00 $ 0.00 $ 0.00
Weighted average common shares outstanding - basic 31,859,812 28,100,066 31,820,898 27,957,789
Weighted average common shares outstanding - diluted 31,859,812 30,817,281 32,564,932 30,675,004